DeepMed Research

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer

Phase 2

Completed

Conditions: Kidney Cancer
Melanoma (Skin)

Interventions: Biological: filgrastim
Biological: therapeutic allogeneic lymphocytes
Drug: cyclophosphamide
Drug: fludarabine phosphate
Procedure: peripheral blood stem cell transplantation

First Posted Date: 2003-01-27

Last Posted Date: 2014-03-07

Lead Sponsor: University of Chicago

Target Recruit Count: 19

Registration Number: NCT00004135

Locations: 🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States

Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Biological: bevacizumab
Drug: carboplatin
Drug: paclitaxel
Procedure: conventional surgery
Procedure: neoadjuvant therapy

First Posted Date: 2003-01-27

Last Posted Date: 2013-02-11

Lead Sponsor: University of Chicago

Target Recruit Count: 8

Registration Number: NCT00025389

Locations: 🇺🇸
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus, Ohio, United States
🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States

Characterizing a 5P-Linked BHR Susceptibility Locus

Completed

Conditions: Asthma
Lung Diseases

First Posted Date: 2000-11-21

Last Posted Date: 2016-01-21

Lead Sponsor: University of Chicago

Registration Number: NCT00006512

Leuprolide in Treating Adults With Hypogonadotropism

Not Applicable

Completed

Conditions: Hypogonadism

First Posted Date: 1999-10-19

Last Posted Date: 2015-03-25

Lead Sponsor: University of Chicago

Target Recruit Count: 45

Registration Number: NCT00004438

Locations: 🇺🇸
University of Chicago Children's Hospital, Chicago, Illinois, United States

Leuprolide in Determining the Cause of Gonadotropin Deficiency

Not Applicable

Completed

Conditions: Hypogonadism

First Posted Date: 1999-10-19

Last Posted Date: 2015-03-26

Lead Sponsor: University of Chicago

Target Recruit Count: 90

Registration Number: NCT00004426

Locations: 🇺🇸
University of Chicago Children's Hospital, Chicago, Illinois, United States

Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11

Not Applicable

Completed

Conditions: Opioid-Related Disorders
Substance-Related Disorders

Interventions: Other: Placebo
Drug: 0.3 % Sevoflurane
Drug: 0.6% Sevoflurane
Drug: 15 % Nitrous oxide
Drug: 30% Nitrous oxide

First Posted Date: 1999-09-21

Last Posted Date: 2015-05-28

Lead Sponsor: University of Chicago

Target Recruit Count: 12

Registration Number: NCT00000259

Locations: 🇺🇸
University of Chicago, Anesthesia & Critical Care, Chicago, Illinois, United States

Effects of Combined Alcohol and Nitrous Oxide Intake - 15

Not Applicable

Completed

Conditions: Opioid-Related Disorders
Substance-Related Disorders

Interventions: Drug: 30% Nitrous oxide
Other: 0 g/Kg ethanol
Other: 0.25 g/Kg ethanol
Other: 0.5 g/KG ethanol

First Posted Date: 1999-09-21

Last Posted Date: 2015-05-27

Lead Sponsor: University of Chicago

Target Recruit Count: 11

Registration Number: NCT00000263

Locations: 🇺🇸
University of Chicago, Anesthesia & Critical Care, Chicago, Illinois, United States

Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14

Not Applicable

Completed

Conditions: Opioid-Related Disorders
Substance-Related Disorders

Interventions: Drug: 30% Nitrous oxide
Other: Placebo
Drug: 0.2% sevoflurane
Drug: 0.4% Sevoflurane

First Posted Date: 1999-09-21

Last Posted Date: 2015-05-27

Lead Sponsor: University of Chicago

Target Recruit Count: 20

Registration Number: NCT00000262

Locations: 🇺🇸
University of Chicago, Anesthesia & Critical Care, Chicago, Illinois, United States

Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8

Not Applicable

Completed

Conditions: Opioid-Related Disorders
Substance-Related Disorders

Interventions: Drug: 80% N2O
Drug: 20% N2O
Drug: 40% N2O
Drug: 60% N2O

First Posted Date: 1999-09-21

Last Posted Date: 2015-05-28

Lead Sponsor: University of Chicago

Target Recruit Count: 11

Registration Number: NCT00000256

Locations: 🇺🇸
University of Chicago, Anesthesia & Critical Care, Chicago, Illinois, United States

Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2

Phase 2

Completed

Conditions: Substance-Related Disorders
Opioid-Related Disorders

Interventions: Drug: 0% N2O
Drug: 40% N2O

First Posted Date: 1999-09-21

Last Posted Date: 2015-05-28

Lead Sponsor: University of Chicago

Target Recruit Count: 12

Registration Number: NCT00000250

Locations: 🇺🇸
University of Chicago, Anesthesia & Critical Care, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy